ANIX

Conviction 5HealthcareScan · Thu, Jun 25, 2026

ANIX$2.60-5.11%

ResistanceSupportVol 14Insider buy

Vol MA14 191.35K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Anixa Biosciences IncPHARMACEUTICAL PREPARATIONSwww.anixa.com ↗

Price2.60

Change-5.11%

Gap+3.10%

Rel volume0.56×

Avg volume173.48K

Avg $ vol460.53K

SMA 202.60

SMA 502.79

SMA 2003.30

Price vs 50-6.82%

Price vs 200-21.16%

MA stackbearish

50/200 cross—

Supertrendup · 2.29

RSI (14)46

MACD hist0.03

MACD crossbull · 6d

Stoch %K / %D43 / 58

ADX (14)27

+DI / −DI15 / 14

RSI divergence—

MACD divergence—

ATR %+6.97%

ADR %6.87%

52w high5.22

52w low2.35

From 52w high-50.19%

Above 52w low+10.64%

New 52w highNo

SqueezeOff

Bollinger width21.76%

%B0.50

Donchian pos43.08%

Donchian high2.97

Donchian low2.32

AVWAP (52w high)3.31

vs AVWAP high-21.48%

AVWAP (52w low)2.70

vs AVWAP low-3.66%

OBV trendFlat

Chaikin MF (20)-0.15

Today vs 20d0.56×

Avg vol (14d)191.35K

Avg vol (20d)173.48K

Avg $ vol (20d)460.53K

Market cap88.46M

RS 3m (vs SPY)-6.47%

RS 6m (vs SPY)-24.71%

RS line new highNo

Trend template0/8

Technical rank21.4

1 week-3.35%

1 month-4.76%

3 months-3.70%

6 months-22.85%

1 year-21.92%

YTD-17.72%

P/E-8.10

P/B6.11

P/S421.24

P/FCF-12.31

EPS-0.3400

Div yield—

ROE-75.49%

ROA-73.51%

Debt/Eq0.03

Current9.79

EV/EBITDA-7.48

Gross margin—

Net margin—

Rev growth0.00%

EPS growth12.96%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value87.35M

Revenue210K

Net income-2.52M

Gross profit—

Free cash flow-7.19M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out34.02M

Employees4

ListedFri, Oct 7, 1983

Free float22.15M

Float %66.1%

Short interest1.01M

Days to cover10.8d

Short volume31.0%

Squeeze score34 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction5 / 100

Pattern quality—

Tech rank21.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.14

Support2.47

Days since event—

Candle confirm—

News sentiment—

Financials as of Thu, Apr 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ANIX

All disclosures →

No recent disclosed trades by Congress in ANIX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ANIX · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Titterton Lewis H jr Director · Common Stock · 2026-06-16	Buy	2.84K	$7K	2026-06-16	2026-06-17
KUMAR AMIT Chief Executive Officer · Common Stock · 2026-06-12	Buy	21K	$53K	2026-06-12	2026-06-16

SEC filings

EDGAR filings in ANIX · 1 recent

EDGAR →

10-K/Q10-QWed, Jun 10, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.